<DOC>
	<DOCNO>NCT00446719</DOCNO>
	<brief_summary>The investigator hypothesize Rellidep effective improving symptom major depression . The available evidence strongly suggest Rellidep contains mood alter ingredient ingredient . This open-label , non-randomized study set validate potential antidepressant activity.The study include secondary aim evaluate effect Rellidep reducing symptom anxiety , common symptom associate symptom depression improve quality life . About twenty-five patient major depressive disorder assign open-label Rellidep ( 2000 mg/day ) period 8 week . All patient assess various measure global improvement , depression , quality life , sexual experience , anxiety measure side effect well standard laboratory test .</brief_summary>
	<brief_title>Safety Antidepressant Effects Rellidep Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Signed write informed consent obtain . Males/Females 2065 year age require new new change medication treatment diagnose major depression . A clinical diagnosis fulfil DSMIVTR criterion Major Depressive Disorder , single episode recurrent . 17Item Hamilton Depression Rating Scale ( HAMD 17item ) total score baseline 18 high Clinical diagnosis depression DSMIVTR Major Depressive Disorder ( single episode/recurrent , e.g . chronic depression and/or refractory depression exclude ) . Judged significant risk suicide history suggest significant current potential self harm . Antidepressant medication ( index antidepressant ) . Women pregnant breastfeeding intend become pregnant next 12 month . Clinically significant organ system disease , e.g . cardiovascular , hepatic , renal , endocrine , gastrointestinal , metabolic , systemic disease . Course electroconvulsive therapy ( ECT ) observational period . Suffer major neurological condition ( i.e. , Parkinson 's disease , Huntington 's disease ) , cerebrovascular disease ( i.e. , stroke ) , metabolic condition ( i.e. , Vitamin B12 deficiency ) , autoimmune condition ( i.e. , systematic lupus erythematosus ) , viral infection ( i.e. , hepatitis , mononucleosis , human immunodeficiency ) , cancer . Current diagnosis Schizophrenia psychotic disorder ( include Schizophreniform Disorder , Schizoaffective Disorder , Delusional Disorder , brief psychotic disorder , psychotic disorder due general medical condition , substance induce psychotic , psychotic disorder otherwise specify ) define DSMIV . ( Sub ) clinical hypo/hyper thyroidism ( e.g . elevate TSH ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>major depression</keyword>
	<keyword>antidepressant</keyword>
	<keyword>quality life</keyword>
	<keyword>anxiety</keyword>
</DOC>